According to the Zhitong Finance APP, Shandong Pharmaceutical Glass (600529.SH) announced that on December 30, 2024, the company received a notice from its controlling shareholder Shandong Luzhong Investment Co., Ltd. (referred to as "Luzhong Investment") regarding the strategic restructuring being planned by Luzhong Investment and the potential change of its controlling shareholder. The main content is as follows: The People's Government of Yiyuan County and China International Pharmaceutical Health Co., Ltd. are planning the restructuring of Luzhong Investment, which may involve a change in the controlling shareholder of Luzhong Investment, thereby leading to a change in the company's indirect controlling shareholder